Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,610.00
+10.00 (0.22%)
Jan 29, 2026, 3:30 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 93.87 billion as of January 29, 2026. Its market cap has decreased by -12.69% in one year.
Market Cap
93.87B
Enterprise Value
106.24B
Revenue
173.80B
Ranking
n/a
PE Ratio
13.16
Stock Price
4,610.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 93.87B, an increase of 216.69%. That is a compound annual growth rate of 6.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 93.87B | 7.21% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilsung Is | 150.18B |
| SAMSUNG PHARM. Co., LTD. | 148.90B |
| HANDOK | 145.37B |
| Kyongbo Pharmaceutical | 140.09B |
| Ildong Holdings | 135.51B |
| Jeil Pharma Holdings | 123.12B |
| CKD Bio | 116.58B |
| Enzychem Lifesciences | 104.26B |